524516
BACPHAR
Start SIP
Invest Now
Start SIP in BACPHAR
Performance
- Low
- ₹44
- High
- ₹47
- 52 Week Low
- ₹27
- 52 Week High
- ₹48
- Open Price₹47
- Previous Close₹45
- Volume3,052
- 50 DMA₹39.23
- 100 DMA₹39.10
- 200 DMA₹37.96
Investment Returns
- Over 1 Month + 25.47%
- Over 3 Month + 5.81%
- Over 6 Month + 21.51%
- Over 1 Year + 3.45%
Smart Investing Starts Here Start SIP with Bacil Pharma for Steady Growth!
Bacil Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 98.1
- PEG Ratio
- 1.5
- Market Cap Cr
- 62
- P/B Ratio
- 2.3
- Average True Range
- 3.28
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- 1.2
- RSI
- 65.22
- MFI
- 94.08
Bacil Pharma Financials
Bacil Pharma Technicals
EMA & SMA
Current Price
₹43.50
-1.36
(-3.03%)
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹40.82
- 50 Day
- ₹39.23
- 100 Day
- ₹39.10
- 200 Day
- ₹37.96
Resistance and Support
44.94
- R3 49.77
- R2 48.34
- R1 46.37
- S1 42.97
- S2 41.54
- S3 39.57
Bacil Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-09-05 | Others | Inter-alia, to consider 1. Fix Date, Place, Timing and Notice for 38th AGM of the Company. 2. Director Report of the Company for the Financial Year 2024-2025. 3. Other business matters. |
| 2025-08-25 | Others | Inter-alia, to consider 1. Discussion on Appointment of M/s Sarang Shivajirao Chavan & Associate as a Statutory Auditor of the Company. 2. Appointment of New Director. 3. Other business matters. |
| 2025-08-12 | Quarterly Results | |
| 2025-07-16 | Others | Inter-alia, to consider 1. Appointment of a new Executive Director and Chief Financial Officer of the Company. 2. Resignation of the present Chief Financial Officer. 3. Other business matters. |
Bacil Pharma F&O
About Bacil Pharma
- NSE Symbol
- BACPHAR
- BSE Symbol
- 524516
- ISIN
- INE711D01018
Similar Stocks to Bacil Pharma
Bacil Pharma FAQs
Bacil Pharma share price is ₹43 As on 21 January, 2026 | 03:29
The Market Cap of Bacil Pharma is ₹62.4 Cr As on 21 January, 2026 | 03:29
The P/E ratio of Bacil Pharma is 98.1 As on 21 January, 2026 | 03:29
The PB ratio of Bacil Pharma is 2.3 As on 21 January, 2026 | 03:29
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.